| 000 | 01906 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516214335.0 | ||
| 264 | 0 | _c20160318 | |
| 008 | 201603s 0 0 eng d | ||
| 022 | _a1863-2661 | ||
| 024 | 7 |
_a10.1007/s00429-014-0798-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJimenez-Mateos, Eva M | |
| 245 | 0 | 0 |
_aAntagomirs targeting microRNA-134 increase hippocampal pyramidal neuron spine volume in vivo and protect against pilocarpine-induced status epilepticus. _h[electronic resource] |
| 260 |
_bBrain structure & function _cJul 2015 |
||
| 300 |
_a2387-99 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aDendritic Spines _xpathology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aElectroencephalography |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 |
_aHippocampus _xpathology |
| 650 | 0 | 4 | _aInjections, Intraventricular |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMicroRNAs _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNeurons _xpathology |
| 650 | 0 | 4 |
_aOligonucleotides _xtherapeutic use |
| 650 | 0 | 4 |
_aPilocarpine _xtoxicity |
| 650 | 0 | 4 |
_aSpatial Memory _xdrug effects |
| 650 | 0 | 4 | _aStatistics, Nonparametric |
| 650 | 0 | 4 |
_aStatus Epilepticus _xchemically induced |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aEngel, Tobias | |
| 700 | 1 | _aMerino-Serrais, Paula | |
| 700 | 1 | _aFernaud-Espinosa, Isabel | |
| 700 | 1 | _aRodriguez-Alvarez, Natalia | |
| 700 | 1 | _aReynolds, James | |
| 700 | 1 | _aReschke, Cristina R | |
| 700 | 1 | _aConroy, Ronan M | |
| 700 | 1 | _aMcKiernan, Ross C | |
| 700 | 1 | _adeFelipe, Javier | |
| 700 | 1 | _aHenshall, David C | |
| 773 | 0 |
_tBrain structure & function _gvol. 220 _gno. 4 _gp. 2387-99 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00429-014-0798-5 _zAvailable from publisher's website |
| 999 |
_c23867847 _d23867847 |
||